BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/11/2014 3:07:00 PM | Browse: 939 | Download: 1008
Publication Name World Journal of Obstetrics and Gynecology
Manuscript ID 1461
Country Thailand
Received
2012-12-13 11:00
Peer-Review Started
2012-12-13 16:43
To Make the First Decision
2013-01-09 15:57
Return for Revision
2013-01-11 12:11
Revised
Second Decision
2013-02-06 12:16
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-02-06 12:56
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
2013-02-24 18:59
Typeset the Manuscript
2013-04-18 12:55
Publish the Manuscript Online
2013-11-17 20:09
ISSN 2218-6220 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Obstetrics & Gynecology
Manuscript Type Topic Highlights
Article Title Neoadjuvant chemotherapy and cytoreductive surgery in epithelial ovarian cancer
Manuscript Source Invited Manuscript
All Author List Siriwan Tangjitgamol, Jitti Hanprasertpong, Marta Cubelli and Claudio Zamagni
Funding Agency and Grant Number
Corresponding Author Siriwan Tangjitgamol, MD, Gynecologic Oncology Unit, Department of Obstetrics and Gynecology, Faculty of Medicine Vajira Hospital, University of Bangkok Metropolis, 681 Samsen Road, Dusit, Bangkok 10300, Thailand. siriwanonco@yahoo.com
Key Words Advanced stage ovarian cancer; Neoadjuvant chemotherapy; Interval debulking surgery
Core Tip Neoadjuvant chemotherapy (NACT) is an option when the primary surgery is expected to be impossible or suboptimal, or when high morbidity is anticipated. Delayed primary surgery or interval debulking surgery (IDS) is performed in patients who show some clinical response to neoadjuvant or induction chemotherapy. Preoperative clinical data to predict surgical outcomes and selection criteria for primary surgery followed by adjuvant chemotherapy or for NACT followed by IDS will be discussed in this chapter.
Publish Date 2013-11-17 20:09
Citation Tangjitgamol S, Hanprasertpong J, Cubelli M, Zamagni C. Neoadjuvant chemotherapy and cytoreductive surgery in epithelial ovarian cancer. World J Obstet Gynecol 2013; 2(4): 153-166
URL http://www.wjgnet.com/2218-6220/full/v2/i4/153.htm
DOI http://dx.doi.org/10.5317/wjog.v2.i4.153
Full Article (PDF) WJOG-2-153.pdf
Manuscript File 1461-Review.doc
Answering Reviewers 1461-Answering reviewers.pdf
Copyright License Agreement 1461-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 1461-Language certificate.pdf
Peer-review Report 1461-Peer review.docx
Scientific Editor Work List 1461-Scientific editor work list.doc